The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 01, 2025

Filed:

Apr. 29, 2022
Applicants:

Jichi Medical University, Tochigi, JP;

Gene Therapy Research Institution Co., Ltd., Kawasaki, JP;

Inventors:

Shin-ichi Muramatsu, Tochigi, JP;

Keiji Oguro, Tochigi, JP;

Kuniko Shimazaki, Tochigi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 35/761 (2015.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61P 25/08 (2006.01); A61P 25/28 (2006.01); C07K 14/705 (2006.01); C12N 15/864 (2006.01);
U.S. Cl.
CPC ...
A61K 48/005 (2013.01); A61K 35/761 (2013.01); A61K 38/177 (2013.01); A61K 45/06 (2013.01); A61K 48/0075 (2013.01); A61P 25/08 (2018.01); A61P 25/28 (2018.01); C07K 14/705 (2013.01); C12N 15/8645 (2013.01); A61K 48/0058 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14143 (2013.01);
Abstract

Provided is a novel gene therapy means for neurological diseases including epilepsy. The present invention provides: a recombinant adeno-associated virus vector for use in the treatment of neurological diseases including epilepsy, which comprises a polynucleotide encoding a protein capable of improving the excitation-inhibiting function of an inhibitory synapse in vivo, preferably neuroligin-2 protein; a pharmaceutical composition comprising said recombinant vector; and others. The present invention also provides a method for treating a disease such as epilepsy using the recombinant vector.


Find Patent Forward Citations

Loading…